Platelet-rich fibrin to reduce pain after lumbar disc surgery
Official title: Efficacy of Platelet Rich Fibrin in the Prevention of Residual Neuropathic Pain Following Disc Herniation Surgery
Run by University Hospital, Strasbourg, France · NCT05196503 · Data updated 2026-11-12
This phase 3 trial tests whether applying platelet-rich fibrin around the nerve roots during lumbar disc surgery can lessen ongoing neuropathic pain after the operation.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg, Bas-Rhin) |
| Status | Recruiting |
| Started | February 23, 2022 |
| Main results expected | February 23, 2022 |
| Study ends | January 2028 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT05196503 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing lumbar disc herniation surgery who have radiating leg pain due to radiculopathy and meet the study’s inclusion criteria.
✕Probably not a fit
Patients who do not respond to PRF or who have exclusion criteria or complications related to surgery may not experience pain relief.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, single-blind, phase 3 study compares adding periradicular platelet-rich fibrin (PRF) during lumbar disc herniation surgery to the standard surgical approach. Participants are adults with lumbar radiculopathy planned for surgery and are assigned to receive either PRF or usual care. Outcomes are evaluated by a blinded assessor to determine the effect on residual post-surgical neuropathic pain. The trial is conducted at a single center in Strasbourg, France, and is sponsored by the University Hospital Strasbourg. Safety and tolerability of the intraoperative PRF application are also monitored.
Why it matters
Potential benefit: If successful, patients may experience lower intensity of residual neuropathic pain after surgery.
How similar studies have gone: Previous approaches using platelet-rich therapies in regenerative contexts show potential for pain reduction, but this exact intraoperative application is relatively novel and requires confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Patient, male or female, \>18 years old at the time of signing informed consent; * Patient for whom a diagnosis of radiculopathy on lumbar disc herniation has been made, and for whom surgery has been scheduled in the Neurosurgery department; * Patient affiliated to a social security health insurance scheme; * Patient able to understand the objectives and risks of research and to give informed, dated and signed consent; * Patient having been informed of the results of the prior medical examination; * Women of childbearing age provided that a negative blood pregnancy test is recorded at the inclusion visit and effective contraception used throughout the study. Exclusion criteria: * Patient with a history of lumbar spinal surgery (multiple herniated discs, herniated disc other than lumbar); * Patient with HIV, active cancer, HBV, HCV (verified by interview); * Patient on long-term systemic corticosteroid therapy; * Patient with an ASA score \> 3 during the consultation with the anesthesiologist; * Inability to give the patient informed information (patient in an emergency or life-threatening situation, difficulties in understanding); * Patient in exclusion period (determined by a previous or ongoing study); * Subject under safeguard of justice; * Subject under curatorship; * Pregnancy; * Breastfeeding.
Where it's running
-
Les Hôpitaux Universitaires
Strasbourg, Bas-Rhin, France Recruiting
Study contacts
- Study coordinator: Erci SALVAT
- Email: eric.salvat@chru-strasbourg.fr
- Phone: +33 3 88 12 85 02
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based pain management for chronic post-treatment pain after head and neck cancer
We’re testing a personalized pain plan to see if tailoring treatment to a patient’s pain type can reduce chronic pain in adults who completed head and neck cancer treatment.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Prevention of chronic postsurgical pain in people who regularly use opioids
This trial tests whether adding a telemedicine post-surgery consult between days 15 and 28 helps reduce long-term pain and opioid use in adults on chronic opioids undergoing elective surgery.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.